These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7422102)

  • 21. Long-term administration of monoamine oxidase inhibitors alters the firing rate and pattern of dopamine neurons in the ventral tegmental area.
    Chenu F; El Mansari M; Blier P
    Int J Neuropsychopharmacol; 2009 May; 12(4):475-85. PubMed ID: 18700056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoamine oxidase and cerebral uptake of dopaminergic drugs.
    Cotzias GC; Tang LC; Ginos JZ
    Proc Natl Acad Sci U S A; 1974 Jul; 71(7):2715-9. PubMed ID: 4137067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypophysectomy does not prevent the enhanced monoamine-mediated behavioural responses following repeated electroconvulsive shocks.
    Nutt DJ; Smith SL; Heal DJ
    Neuropharmacology; 1982 Sep; 21(9):881-4. PubMed ID: 7145040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asymmetric behavioral and biochemical effects of unilateral injections of 6-hydroxydopamine into the lateral brain ventricle of the rat.
    Vetulani J; Reichenberg K; Wiszniowska G
    Eur J Pharmacol; 1972 Aug; 19(2):231-8. PubMed ID: 5071793
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibitory effects of 6-hydroxydopamine on the clonic convulsions induced by electroshock and decapitation.
    Fukuda T; Araki Y; Suenaga N
    Neuropharmacology; 1975 Aug; 14(8):579-83. PubMed ID: 1178115
    [No Abstract]   [Full Text] [Related]  

  • 26. DSP-4 lesioning prevents the enhancement of dopamine and 5-hydroxytryptamine mediated behavioural changes by repeated electroconvulsive shock.
    Heal DJ; Davies CL; Goodwin GM
    Eur J Pharmacol; 1985 Sep; 115(1):117-21. PubMed ID: 4043230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relative significance of norepinephrine, dopamine and 5-hydroxytryptamine in electroshock seizure in the rat.
    Jobe PC; Stull RE; Geiger PF
    Neuropharmacology; 1974 Nov; 13(10-11):961-8. PubMed ID: 4548169
    [No Abstract]   [Full Text] [Related]  

  • 28. [Monoaminergic systems of the brain and behavior].
    Budantsev AIu; Azarashvili AA; Zharikov SI; Arkhipov VI
    Usp Fiziol Nauk; 1977; 8(2):53-74. PubMed ID: 197724
    [No Abstract]   [Full Text] [Related]  

  • 29. Regulatory effects of neurotransmitters on electroshock and pentylenetetrazol seizures.
    Burley ES; Ferrendelli JA
    Fed Proc; 1984 Jul; 43(10):2521-4. PubMed ID: 6145628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Responses of developing rats to L-tryptophan plus an MAOI-I. Monitoring changes in behaviour, brain 5-HT and tryptophan.
    Atterwill CK; Green AR
    Neuropharmacology; 1980 Apr; 19(4):325-35. PubMed ID: 7383278
    [No Abstract]   [Full Text] [Related]  

  • 31. The biochemistry of the functional psychoses.
    Weil-Malherbe H
    Adv Enzymol Relat Areas Mol Biol; 1967; 29():479-553. PubMed ID: 4302714
    [No Abstract]   [Full Text] [Related]  

  • 32. [Neurochemical and behavioral study on the mechanism of the antidepressant and anxiolytic effect of co-administration of lithium and monoamine oxidase inhibitors].
    Kitaichi Y
    Hokkaido Igaku Zasshi; 2004 Jan; 79(1):93-101. PubMed ID: 14978979
    [No Abstract]   [Full Text] [Related]  

  • 33. An Overview of Analytical Methods for the Determination of Monoamine Oxidase Inhibitors in Pharmaceutical Formulations and Biological Fluids.
    Saka C
    Crit Rev Anal Chem; 2017 Jan; 47(1):1-23. PubMed ID: 27715253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of gestational exposure to monoamine oxidase inhibitors in rats: preliminary behavioral and neurochemical studies.
    Whitaker-Azmitia PM; Zhang X; Clarke C
    Neuropsychopharmacology; 1994 Oct; 11(2):125-32. PubMed ID: 7840864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressant monoamine oxidase inhibitors enhance serotonin but not norepinephrine neurotransmission.
    Blier P; de Montigny C
    Psychopharmacol Ser; 1987; 3():127-34. PubMed ID: 3029752
    [No Abstract]   [Full Text] [Related]  

  • 36. Possible role of brain serotonin and dopamine in controlling male sexual behavior.
    Gessa GL; Tagliamonte A
    Adv Biochem Psychopharmacol; 1974; 11(0):217-28. PubMed ID: 4276859
    [No Abstract]   [Full Text] [Related]  

  • 37. Some effects of a monoamine oxidase inhibitor upon changes produced by centrally administered amines.
    SCHAIN RJ
    Br J Pharmacol Chemother; 1961 Oct; 17(2):261-6. PubMed ID: 14497993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased anticonvulsant activity of carbamazepine in 6-hydroxydopamine-treated rats.
    Quattrone A; Samanin R
    Eur J Pharmacol; 1977 Feb; 41(3):336-6. PubMed ID: 837975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
    Nguyen TB; Angers M
    Biochem Pharmacol; 1987 May; 36(10):1731-5. PubMed ID: 3109430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoamine oxidase in rat arteries: evidence for different forms and selective localization.
    Coquil JF; Goridis C; Mack G; Neff NH
    Br J Pharmacol; 1973 Aug; 48(4):590-9. PubMed ID: 4788203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.